CMV Infection in Adolescent Males
Stopped early
Conditions studied: Cytomegalovirus Infections
In brief
The purpose of this study is to find out more about cytomegalovirus (CMV) and how it is spread between people. One thousand adolescent males ages 12-17 years will participate in this study. Participants will be given a questionnaire about risk factors for CMV. A small blood sample (2-3 teaspoons) will be taken to test for CMV infection. Subjects that are CMV seronegative may participate in the second part of this study, which will involve returning to the clinic at regularly scheduled visit times to provide blood, urine, and saliva (spit) samples. This part of the study will take at least 24 months to complete. Subjects that test positive for CMV during the 2nd portion of the study will be invited to participate in the 3rd part of the study. This part of the study will require 8 regularly scheduled visits to provide blood, urine and saliva samples, over a 12-month period. The maximum amount of time a subject will participate in the study is 36 months.
Key facts
- Study ID
- NCT00302029
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 411
- Starts
- 2006-06-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2011-11-11
Who can join
Age: 12 and older, up to 17. Sex: male. Healthy volunteers: accepted.
Where it is running
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- Vanderbilt University — Nashville, Tennessee, United States
- The University of Texas Medical Branch — Galveston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.